What is COVAX and why is Canada getting backlash for receiving vaccines from it? – CBC

Canada set to receive an initial 1.9 million Oxford-AstraZeneca doses from global vaccine-sharing initiative

 Feb 05, 2021

Amid a massive immunization effort, the Canadian government is finding itself on the defensive for its decision to receive COVID-19 vaccines from the global initiative known as COVAX.

Canada will receive 1.9 million doses of the Oxford-AstraZeneca vaccine — pending regulatory approval — from the program by the end of June, according to an update released by COVAX on Wednesday on the first phase of its vaccine delivery. Federal opposition leaders decried it as an embarrassment and “the wrong decision” by the government.

In light of the controversy, here’s what you need to know about what COVAX is, who is involved and how Canada factors in.

Read more: https://www.cbc.ca/news/canada/covax-explainer-canada-backlash-1.5902072

NationTalk Partners & Sponsors Learn More